Filed: 11/14/2025ACC: 0001999371-25-017920
📋 What this filing means
FIRST LIGHT ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $1.06B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$1.06B
Total AUM (reported)
101.30M
Total Shares
Allocation by class
COMMON STOCKS$1.06B100.0%
Portfolio Concentration
Top 3$282.33M26.6%
4–10$299.61M28.2%
11–25$353.70M33.3%
Rest$125.17M11.8%
Top 3 weight
26.6%
Top 10 weight
54.9%
Voting Authority Distribution
Total shares with voting rights: 101.30M
Sole
Full voting authority
101.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
AXOGEN INC
SOLEShares5.81M
TypeSH
Market value$103.57M
9.76%
Sole
5.81M
Shared
0.00
None
0.00
PERFORMANT HEALTHCARE INC
SOLEShares11.72M
TypeSH
Market value$90.58M
8.54%
Sole
11.72M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS LIMITED
SOLEShares3.64M
TypeSH
Market value$88.17M
8.31%
Sole
3.64M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares9.93M
TypeSH
Market value$76.64M
7.22%
Sole
9.93M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares3.36M
TypeSH
Market value$45.61M
4.30%
Sole
3.36M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS INC
SOLEShares941.52K
TypeSH
Market value$39.21M
3.70%
Sole
941.52K
Shared
0.00
None
0.00
HEALTH CATALYST INC
SOLEShares13.44M
TypeSH
Market value$38.29M
3.61%
Sole
13.44M
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC
SOLEShares541.54K
TypeSH
Market value$33.95M
3.20%
Sole
541.54K
Shared
0.00
None
0.00
TWIST BIOSCIENCE CORPORATION
SOLEShares1.19M
TypeSH
Market value$33.62M
3.17%
Sole
1.19M
Shared
0.00
None
0.00
LENZ THERAPEUTICS INC
SOLEShares693.04K
TypeSH
Market value$32.28M
3.04%
Sole
693.04K
Shared
0.00
None
0.00
ORGANOGENESIS HOLDINGS INC
SOLEShares7.50M
TypeSH
Market value$31.64M
2.98%
Sole
7.50M
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares890.36K
TypeSH
Market value$31.39M
2.96%
Sole
890.36K
Shared
0.00
None
0.00
ANAPTYS BIO INC
SOLEShares990.16K
TypeSH
Market value$30.32M
2.86%
Sole
990.16K
Shared
0.00
None
0.00
SI-BONE INC
SOLEShares1.92M
TypeSH
Market value$28.23M
2.66%
Sole
1.92M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares292.66K
TypeSH
Market value$28.02M
2.64%
Sole
292.66K
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES
SOLEShares155.10K
TypeSH
Market value$26.68M
2.51%
Sole
155.10K
Shared
0.00
None
0.00
MIMEDX GROUP INC
SOLEShares3.65M
TypeSH
Market value$25.50M
2.40%
Sole
3.65M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1.41M
TypeSH
Market value$22.95M
2.16%
Sole
1.41M
Shared
0.00
None
0.00
908 DEVICES INC
SOLEShares2.51M
TypeSH
Market value$21.99M
2.07%
Sole
2.51M
Shared
0.00
None
0.00
MERUS NV
SOLEShares224.08K
TypeSH
Market value$21.10M
1.99%
Sole
224.08K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares180.48K
TypeSH
Market value$18.23M
1.72%
Sole
180.48K
Shared
0.00
None
0.00
GUARDANT HEALTH
SOLEShares280K
TypeSH
Market value$17.49M
1.65%
Sole
280K
Shared
0.00
None
0.00
KORU MEDICAL SYSTEMS INC
SOLEShares4.53M
TypeSH
Market value$17.34M
1.63%
Sole
4.53M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HOLDINGS
SOLEShares418.36K
TypeSH
Market value$17.15M
1.62%
Sole
418.36K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.07M
TypeSH
Market value$15.67M
1.48%
Sole
1.07M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AXOGEN INCSOLE | Common Stocks | 5.81M | SH | $103.57M 9.76% | 5.81M | 0.00 | 0.00 |
PERFORMANT HEALTHCARE INCSOLE | Common Stocks | 11.72M | SH | $90.58M 8.54% | 11.72M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS LIMITEDSOLE | Common Stocks | 3.64M | SH | $88.17M 8.31% | 3.64M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | Common Stocks | 9.93M | SH | $76.64M 7.22% | 9.93M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | Common Stocks | 3.36M | SH | $45.61M 4.30% | 3.36M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INCSOLE | Common Stocks | 941.52K | SH | $39.21M 3.70% | 941.52K | 0.00 | 0.00 |
HEALTH CATALYST INCSOLE | Common Stocks | 13.44M | SH | $38.29M 3.61% | 13.44M | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INCSOLE | Common Stocks | 541.54K | SH | $33.95M 3.20% | 541.54K | 0.00 | 0.00 |
TWIST BIOSCIENCE CORPORATIONSOLE | Common Stocks | 1.19M | SH | $33.62M 3.17% | 1.19M | 0.00 | 0.00 |
LENZ THERAPEUTICS INCSOLE | Common Stocks | 693.04K | SH | $32.28M 3.04% | 693.04K | 0.00 | 0.00 |
ORGANOGENESIS HOLDINGS INCSOLE | Common Stocks | 7.50M | SH | $31.64M 2.98% | 7.50M | 0.00 | 0.00 |
ATRICURE INCSOLE | Common Stocks | 890.36K | SH | $31.39M 2.96% | 890.36K | 0.00 | 0.00 |
ANAPTYS BIO INCSOLE | Common Stocks | 990.16K | SH | $30.32M 2.86% | 990.16K | 0.00 | 0.00 |
SI-BONE INCSOLE | Common Stocks | 1.92M | SH | $28.23M 2.66% | 1.92M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | Common Stocks | 292.66K | SH | $28.02M 2.64% | 292.66K | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIESSOLE | Common Stocks | 155.10K | SH | $26.68M 2.51% | 155.10K | 0.00 | 0.00 |
MIMEDX GROUP INCSOLE | Common Stocks | 3.65M | SH | $25.50M 2.40% | 3.65M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | Common Stocks | 1.41M | SH | $22.95M 2.16% | 1.41M | 0.00 | 0.00 |
908 DEVICES INCSOLE | Common Stocks | 2.51M | SH | $21.99M 2.07% | 2.51M | 0.00 | 0.00 |
MERUS NVSOLE | Common Stocks | 224.08K | SH | $21.10M 1.99% | 224.08K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | Common Stocks | 180.48K | SH | $18.23M 1.72% | 180.48K | 0.00 | 0.00 |
GUARDANT HEALTHSOLE | Common Stocks | 280K | SH | $17.49M 1.65% | 280K | 0.00 | 0.00 |
KORU MEDICAL SYSTEMS INCSOLE | Common Stocks | 4.53M | SH | $17.34M 1.63% | 4.53M | 0.00 | 0.00 |
ESTABLISHMENT LABS HOLDINGSSOLE | Common Stocks | 418.36K | SH | $17.15M 1.62% | 418.36K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | Common Stocks | 1.07M | SH | $15.67M 1.48% | 1.07M | 0.00 | 0.00 |
Page 1 of 2